Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAFor years, individualized obstructive sleep apnea care has been more aspiration than routine practice. Pharmacologic therapies may help change that.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision | 0 | 5 | 22-06-2026 |
| 2 | Consumer Sleep Data Likely Houses Clues to Cases of Undiagnosed OSA | 0 | 6 | 30-06-2026 |
| 3 | Semaglutide Associated With Lower Incidence of OSA in Post Hoc Analysis | 2 | 6 | 26-06-2026 |
| 4 | Bryggs Medical Launches ULTepap 2 with Adjustable Pressure Settings | 0 | 5 | 06-07-2026 |
| 5 | SovaSage Releases AI-Powered Tool for CPAP Patient Management | 0 | 7 | 13-07-2026 |
| 6 | Health Canada Approves Zepbound for OSA in Adults With Obesity | 5 | 8 | 25-06-2026 |
| 7 | Drug Used Off-Label for Insomnia Improves Sleep But Impairs Next-Day Alertness in OSA Patients | 0 | 7 | 10-06-2026 |
| 8 | Narcolepsy Treatments Are Advancing. Can Access? | 0 | 7 | 14-07-2026 |
| 9 | Lilly’s Investigational Triple Agonist Retatrutide Reduces OSA Severity in Phase 3 Trial | 6 | 7 | 23-06-2026 |
| 10 | She Never Made It to Her Sleep Study | 0 | 7 | 24-06-2026 |